Clinical Trial Assessing Godex Carnitine Orotate Complex in Nonalcoholic Fatty Liver Disease Patients for Efficacy - Trial NCT06152991
Access comprehensive clinical trial information for NCT06152991 through Pure Global AI's free database. This Phase 3 trial is sponsored by Yoon Jun Kim and is currently Enrolling by invitation. The study focuses on Non-Alcoholic Fatty Liver Disease. Target enrollment is 196 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Yoon Jun Kim
Seoul National University Hospital
Timeline & Enrollment
Phase 3
Sep 25, 2023
Feb 26, 2027
Primary Outcome
Change in intrahepatic fat content measured by MRI-PDFF
Summary
the purpose of this clinical trial is to assess the efficacy and safety of Orotic Acid
 Carnitine Complex Capsules (Godex®) in comparison to a placebo control group in patients with
 Non-Alcoholic Fatty Liver Disease (NAFLD).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06152991
Non-Device Trial